| WVW | Name: | (3aS,4R,9bR)-4-(4-hydroxyphenyl)-2,3,3a,4,5,9b-hexahydro-1H-cyclopenta[c]quinoline-8-sulfonamide | Formula: | C18 H20 N2 O3 S | SMILES: | NS(=O)(=O)c1ccc2NC(C3CCCC3c2c1)c1ccc(O)cc1 | InChi: | InChI=1S/C18H20N2O3S/c19-24(22,23)13-8-9-17-16(10-13)14-2-1-3-15(14)18(20-17)11-4-6-12(21)7-5-11/h4-10,14-15,18,20-21H,1-3H2,(H2,19,22,23)/t14-,15+,18+/m1/s1 | Definition date: | 2022-10-21 | Last modified: | 2022-12-23 | Release date: | 2022-12-28 | Identifier: | (3aS,4R,9bR)-4-(4-hydroxyphenyl)-2,3,3a,4,5,9b-hexahydro-1H-cyclopenta[c]quinoline-8-sulfonamide |
|
| WJ6 | Name: | 1-[(2E)-4-{5-carbamoyl-2-[(1-ethyl-3-methyl-1H-pyrazole-5-carbonyl)amino]-7-[3-(morpholin-4-yl)propoxy]-1H-benzimidazol-1-yl}but-2-en-1-yl]-2-[(1-ethyl-3-methyl-1H-pyrazole-5-carbonyl)amino]-7-methyl-1H-furo[3,2-e]benzimidazole-5-carboxamide | Formula: | C44 H51 N13 O7 | SMILES: | Cc1cc(n(CC)n1)C(=O)Nc1nc2cc(C(N)=O)c3oc(C)cc3c2n1CC=CCn1c(NC(=O)c2cc(C)nn2CC)nc2cc(cc(OCCCN3CCOCC3)c21)C(N)=O | InChi: | InChI=1S/C44H51N13O7/c1-6-56-33(19-25(3)51-56)41(60)49-43-48-32-24-30(40(46)59)38-29(21-27(5)64-38)36(32)54(43)12-8-9-13-55-37-31(47-44(55)50-42(61)34-20-26(4)52-57(34)7-2)22-28(39(45)58)23-35(37)63-16-10-11-53-14-17-62-18-15-53/h8-9,19-24H,6-7,10-18H2,1-5H3,(H2,45,58)(H2,46,59)(H,47,50,61)(H,48,49,60)/b9-8+ | Definition date: | 2022-09-13 | Last modified: | 2022-12-23 | Release date: | 2022-12-28 | Identifier: | 1-[(2E)-4-{5-carbamoyl-2-[(1-ethyl-3-methyl-1H-pyrazole-5-carbonyl)amino]-7-[3-(morpholin-4-yl)propoxy]-1H-benzimidazol-1-yl}but-2-en-1-yl]-2-[(1-ethyl-3-methyl-1H-pyrazole-5-carbonyl)amino]-7-methyl-1H-furo[3,2-e]benzimidazole-5-carboxamide |
|
| XZ9 | Name: | 1-[6-{[(3M)-4-amino-3-(2-amino-1,3-benzoxazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]methyl}-3,4-dihydroisoquinolin-2(1H)-yl]-3-hydroxypropan-1-one | Formula: | C25 H24 N8 O3 | SMILES: | OCCC(=O)N1Cc2ccc(cc2CC1)Cn1nc(c2cc3nc(N)oc3cc2)c2c(N)ncnc21 | InChi: | InChI=1S/C25H24N8O3/c26-23-21-22(16-3-4-19-18(10-16)30-25(27)36-19)31-33(24(21)29-13-28-23)11-14-1-2-17-12-32(20(35)6-8-34)7-5-15(17)9-14/h1-4,9-10,13,34H,5-8,11-12H2,(H2,27,30)(H2,26,28,29) | Definition date: | 2022-12-14 | Last modified: | 2022-12-23 | Release date: | 2022-12-28 | Identifier: | 1-[6-{[(3M)-4-amino-3-(2-amino-1,3-benzoxazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]methyl}-3,4-dihydroisoquinolin-2(1H)-yl]-3-hydroxypropan-1-one |
|
| K8R | Name: | ~{N}-(3-morpholin-4-ylpropyl)-2-(naphthalen-1-ylamino)-1,3-thiazole-4-carboxamide | Formula: | C21 H24 N4 O2 S | SMILES: | O=C(NCCCN1CCOCC1)c2csc(Nc3cccc4ccccc34)n2 | InChi: | InChI=1S/C21H24N4O2S/c26-20(22-9-4-10-25-11-13-27-14-12-25)19-15-28-21(24-19)23-18-8-3-6-16-5-1-2-7-17(16)18/h1-3,5-8,15H,4,9-14H2,(H,22,26)(H,23,24) | Definition date: | 2022-05-19 | Last modified: | 2022-12-23 | Release date: | 2022-11-16 | Identifier: | ~{N}-(3-morpholin-4-ylpropyl)-2-(naphthalen-1-ylamino)-1,3-thiazole-4-carboxamide |
|
| OJL | Name: | 3-[(6,7-dimethoxyquinazolin-4-yl)oxy]-N-{4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-4-methylbenzamide | Formula: | C32 H34 F3 N5 O4 | SMILES: | CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(Oc4ncnc5cc(OC)c(OC)cc54)c3)cc2C(F)(F)F)CC1 | InChi: | InChI=1S/C32H34F3N5O4/c1-5-39-10-12-40(13-11-39)18-22-8-9-23(15-25(22)32(33,34)35)38-30(41)21-7-6-20(2)27(14-21)44-31-24-16-28(42-3)29(43-4)17-26(24)36-19-37-31/h6-9,14-17,19H,5,10-13,18H2,1-4H3,(H,38,41) | Definition date: | 2022-05-09 | Last modified: | 2022-12-23 | Release date: | 2022-12-28 | Identifier: | 3-[(6,7-dimethoxyquinazolin-4-yl)oxy]-N-{4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-4-methylbenzamide |
|
| Q4C | Name: | ~{N}1-[[3,4-bis(fluoranyl)phenyl]methyl]-4-chloranyl-6-fluoranyl-~{N}3-(3-methyl-5-morpholin-4-yl-pyridin-2-yl)benzene-1,3-dicarboxamide | Formula: | C25 H22 Cl F3 N4 O3 | SMILES: | Cc1cc(cnc1NC(=O)c2cc(c(F)cc2Cl)C(=O)NCc3ccc(F)c(F)c3)N4CCOCC4 | InChi: | InChI=1S/C25H22ClF3N4O3/c1-14-8-16(33-4-6-36-7-5-33)13-30-23(14)32-25(35)17-10-18(21(28)11-19(17)26)24(34)31-12-15-2-3-20(27)22(29)9-15/h2-3,8-11,13H,4-7,12H2,1H3,(H,31,34)(H,30,32,35) | Definition date: | 2022-10-13 | Last modified: | 2022-12-23 | Release date: | 2022-12-28 | Identifier: | ~{N}1-[[3,4-bis(fluoranyl)phenyl]methyl]-4-chloranyl-6-fluoranyl-~{N}3-(3-methyl-5-morpholin-4-yl-pyridin-2-yl)benzene-1,3-dicarboxamide |
|
| N36 | Name: | 3-ethoxy-4-hydroxybenzaldehyde | Formula: | C9 H10 O3 | SMILES: | CCOc1cc(ccc1O)C=O | InChi: | InChI=1S/C9H10O3/c1-2-12-9-5-7(6-10)3-4-8(9)11/h3-6,11H,2H2,1H3 | Synonyms: | Ethyl vanillin | Definition date: | 2022-03-23 | Last modified: | 2022-12-09 | Release date: | 2022-12-14 | Identifier: | 3-ethoxy-4-hydroxybenzaldehyde |
|
| RFO | Name: | 1-(4-chloranylindol-1-yl)-2-methoxy-ethanone | Formula: | C11 H10 Cl N O2 | SMILES: | COCC(=O)n1ccc2c(Cl)cccc12 | InChi: | InChI=1S/C11H10ClNO2/c1-15-7-11(14)13-6-5-8-9(12)3-2-4-10(8)13/h2-6H,7H2,1H3 | Definition date: | 2022-11-30 | Last modified: | 2022-12-09 | Release date: | 2022-12-14 | Identifier: | 1-(4-chloranylindol-1-yl)-2-methoxy-ethanone |
|
| RIX | Name: | methyl 2-(4-chloranylindol-1-yl)-2-oxidanylidene-ethanoate | Formula: | C11 H8 Cl N O3 | SMILES: | COC(=O)C(=O)n1ccc2c(Cl)cccc12 | InChi: | InChI=1S/C11H8ClNO3/c1-16-11(15)10(14)13-6-5-7-8(12)3-2-4-9(7)13/h2-6H,1H3 | Definition date: | 2022-11-30 | Last modified: | 2022-12-09 | Release date: | 2022-12-14 | Identifier: | methyl 2-(4-chloranylindol-1-yl)-2-oxidanylidene-ethanoate |
|
| AKQ | Name: | (2S,4R)-1-acetyl-4-((5-chloropyrimidin-2-yl)amino)-2-methyl-1,2,3,4-tetrahydroquinoline-6-carboxamide | Formula: | C17 H18 Cl N5 O2 | SMILES: | C[CH]1C[CH](Nc2ncc(Cl)cn2)c3cc(ccc3N1C(C)=O)C(N)=O | InChi: | InChI=1S/C17H18ClN5O2/c1-9-5-14(22-17-20-7-12(18)8-21-17)13-6-11(16(19)25)3-4-15(13)23(9)10(2)24/h3-4,6-9,14H,5H2,1-2H3,(H2,19,25)(H,20,21,22)/t9-,14+/m0/s1 | Synonyms: | (2S,4R)-4-[(5-chloranylpyrimidin-2-yl)amino]-1-ethanoyl-2-methyl-3,4-dihydro-2H-quinoline-6-carboxamide | Definition date: | 2021-11-30 | Last modified: | 2022-12-09 | Release date: | 2022-12-14 | Identifier: | (2~{S},4~{R})-4-[(5-chloranylpyrimidin-2-yl)amino]-1-ethanoyl-2-methyl-3,4-dihydro-2~{H}-quinoline-6-carboxamide |
|
| E1I | Name: | N-[5-chloro-2-(morpholin-4-yl)pyridin-4-yl]-2-[5-(3-cyano-4-hydroxy-5-methylphenyl)-3-methyl-2-(1-methyl-1H-pyrazol-4-yl)-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl]acetamide | Formula: | C30 H28 Cl N9 O4 | SMILES: | N#Cc1cc(cc(C)c1O)c1cn(CC(=O)Nc2cc(ncc2Cl)N2CCOCC2)c2N=C(c3cn(C)nc3)N(C)C(=O)c12 | InChi: | InChI=1S/C30H28ClN9O4/c1-17-8-18(9-19(11-32)27(17)42)21-15-40(29-26(21)30(43)38(3)28(36-29)20-12-34-37(2)14-20)16-25(41)35-23-10-24(33-13-22(23)31)39-4-6-44-7-5-39/h8-10,12-15,42H,4-7,16H2,1-3H3,(H,33,35,41) | Definition date: | 2021-12-01 | Last modified: | 2022-12-09 | Release date: | 2022-12-14 | Identifier: | N-[5-chloro-2-(morpholin-4-yl)pyridin-4-yl]-2-[5-(3-cyano-4-hydroxy-5-methylphenyl)-3-methyl-2-(1-methyl-1H-pyrazol-4-yl)-4-oxo-3,4-dihydro-7H-pyrrolo[2,3-d]pyrimidin-7-yl]acetamide |
|
| E2E | Name: | 3-chloro-5-{1-[2-({5-chloro-2-[(3S)-3-methylmorpholin-4-yl]pyridin-4-yl}amino)-2-oxoethyl]-4-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl}-2-hydroxybenzamide | Formula: | C26 H23 Cl2 F N6 O4 | SMILES: | NC(=O)c1cc(cc(Cl)c1O)c1cn(CC(=O)Nc2cc(ncc2Cl)N2CCOCC2C)c2nccc(F)c21 | InChi: | InChI=1S/C26H23Cl2FN6O4/c1-13-12-39-5-4-35(13)21-8-20(18(28)9-32-21)33-22(36)11-34-10-16(23-19(29)2-3-31-26(23)34)14-6-15(25(30)38)24(37)17(27)7-14/h2-3,6-10,13,37H,4-5,11-12H2,1H3,(H2,30,38)(H,32,33,36)/t13-/m0/s1 | Definition date: | 2021-12-01 | Last modified: | 2022-12-09 | Release date: | 2022-12-14 | Identifier: | 3-chloro-5-{1-[2-({5-chloro-2-[(3S)-3-methylmorpholin-4-yl]pyridin-4-yl}amino)-2-oxoethyl]-4-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl}-2-hydroxybenzamide |
|
| OL0 | Name: | (1~{S},10~{R},20~{E})-10-[(1,7-dimethylindazol-5-yl)methyl]-12-methyl-15,18-dioxa-9,12,24,26-tetrazapentacyclo[20.5.2.1^{1,4}.1^{3,7}.0^{25,28}]hentriaconta-3(30),4,6,20,22,24,28-heptaene-8,11,27-trione | Formula: | C36 H38 N6 O5 | SMILES: | CN1CCOCCOCC=Cc2cnc3NC(=O)[C]4(Cc5ccc(cc5C4)C(=O)N[CH](Cc6cc(C)c7n(C)ncc7c6)C1=O)c3c2 | InChi: | InChI=1S/C36H38N6O5/c1-22-13-24(14-28-21-38-42(3)31(22)28)16-30-34(44)41(2)8-10-47-12-11-46-9-4-5-23-15-29-32(37-20-23)40-35(45)36(29)18-26-7-6-25(33(43)39-30)17-27(26)19-36/h4-7,13-15,17,20-21,30H,8-12,16,18-19H2,1-3H3,(H,39,43)(H,37,40,45)/b5-4+/t30-,36+/m1/s1 | Definition date: | 2022-09-14 | Last modified: | 2022-12-02 | Release date: | 2022-12-07 | Identifier: | (1~{S},10~{R},20~{E})-10-[(1,7-dimethylindazol-5-yl)methyl]-12-methyl-15,18-dioxa-9,12,24,26-tetrazapentacyclo[20.5.2.1^{1,4}.1^{3,7}.0^{25,28}]hentriaconta-3(30),4,6,20,22,24,28-heptaene-8,11,27-trione |
|
| X3W | Name: | 1-{(4S,11aM)-2-[(4R)-2-oxo-4-(propan-2-yl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-L-prolinamide | Formula: | C22 H27 N5 O4 | SMILES: | CC(C)C1COC(=O)N1c1nc2c3ccc(cc3OCCn2c1)N1CCCC1C(N)=O | InChi: | InChI=1S/C22H27N5O4/c1-13(2)17-12-31-22(29)27(17)19-11-25-8-9-30-18-10-14(5-6-15(18)21(25)24-19)26-7-3-4-16(26)20(23)28/h5-6,10-11,13,16-17H,3-4,7-9,12H2,1-2H3,(H2,23,28)/t16-,17-/m0/s1 | Definition date: | 2022-10-26 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 1-{(4S,11aM)-2-[(4R)-2-oxo-4-(propan-2-yl)-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}-L-prolinamide |
|
| JM3 | Name: | 5-(morpholin-4-ylmethyl)quinolin-8-ol | Formula: | C14 H16 N2 O2 | SMILES: | Oc1ccc(CN2CCOCC2)c3cccnc13 | InChi: | InChI=1S/C14H16N2O2/c17-13-4-3-11(10-16-6-8-18-9-7-16)12-2-1-5-15-14(12)13/h1-5,17H,6-10H2 | Definition date: | 2022-05-05 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 5-(morpholin-4-ylmethyl)quinolin-8-ol |
|
| A7X | Name: | 4-[(E)-(6-azanyl-1-methyl-2-oxidanylidene-indol-3-ylidene)methyl]benzoic acid | Formula: | C17 H14 N2 O3 | SMILES: | CN1C(=O)C(=Cc2ccc(cc2)C(O)=O)c3ccc(N)cc13 | InChi: | InChI=1S/C17H14N2O3/c1-19-15-9-12(18)6-7-13(15)14(16(19)20)8-10-2-4-11(5-3-10)17(21)22/h2-9H,18H2,1H3,(H,21,22)/b14-8+ | Synonyms: | (E)-4-((6-amino-1-methyl-2-oxoindolin-3-ylidene)methyl)benzoic acid | Definition date: | 2021-11-25 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 4-[(~{E})-(6-azanyl-1-methyl-2-oxidanylidene-indol-3-ylidene)methyl]benzoic acid |
|
| QAX | Name: | 6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-ol | Formula: | C17 H23 N3 O3 | SMILES: | Oc1ncnc2cc(OCCCN3CCCCC3)c(OC)cc21 | InChi: | InChI=1S/C17H23N3O3/c1-22-15-10-13-14(18-12-19-17(13)21)11-16(15)23-9-5-8-20-6-3-2-4-7-20/h10-12H,2-9H2,1H3,(H,18,19,21) | Definition date: | 2022-06-05 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-ol |
|
| QB3 | Name: | 6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-ol | Formula: | C16 H21 N3 O3 | SMILES: | CN1CCC(COc2cc3ncnc(O)c3cc2OC)CC1 | InChi: | InChI=1S/C16H21N3O3/c1-19-5-3-11(4-6-19)9-22-15-8-13-12(7-14(15)21-2)16(20)18-10-17-13/h7-8,10-11H,3-6,9H2,1-2H3,(H,17,18,20) | Definition date: | 2022-06-05 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-ol |
|
| QEU | Name: | 4-[4-(6,7-dimethoxyquinazolin-4-yl)piperazin-1-yl]butan-1-ol | Formula: | C18 H26 N4 O3 | SMILES: | COc1cc2c(cc1OC)ncnc2N1CCN(CCCCO)CC1 | InChi: | InChI=1S/C18H26N4O3/c1-24-16-11-14-15(12-17(16)25-2)19-13-20-18(14)22-8-6-21(7-9-22)5-3-4-10-23/h11-13,23H,3-10H2,1-2H3 | Definition date: | 2022-06-07 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 4-[4-(6,7-dimethoxyquinazolin-4-yl)piperazin-1-yl]butan-1-ol |
|
| AI0 | Name: | 1-(8-oxidanylquinolin-2-yl)-N-(phenylmethyl)methanimine oxide | Formula: | C17 H14 N2 O2 | SMILES: | Oc1cccc2ccc(C=[N+]([O-])Cc3ccccc3)nc12 | InChi: | InChI=1S/C17H14N2O2/c20-16-8-4-7-14-9-10-15(18-17(14)16)12-19(21)11-13-5-2-1-3-6-13/h1-10,12,20H,11H2/b19-12- | Synonyms: | (Z)-N-benzyl-1-(8-hydroxyquinolin-2-yl)methanimine oxide | Definition date: | 2021-11-26 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | 1-(8-oxidanylquinolin-2-yl)-~{N}-(phenylmethyl)methanimine oxide |
|
| AI6 | Name: | N-tert-butyl-1-[8-[3-(4-prop-2-ynylpiperazin-1-yl)propoxy]quinolin-2-yl]methanimine oxide | Formula: | C24 H32 N4 O2 | SMILES: | CC(C)(C)[N+]([O-])=Cc1ccc2cccc(OCCCN3CCN(CC3)CC#C)c2n1 | InChi: | InChI=1S/C24H32N4O2/c1-5-12-26-14-16-27(17-15-26)13-7-18-30-22-9-6-8-20-10-11-21(25-23(20)22)19-28(29)24(2,3)4/h1,6,8-11,19H,7,12-18H2,2-4H3/b28-19- | Synonyms: | (Z)-N-tert-butyl-1-(8-(3-(4-(prop-2-yn-1-yl)piperazin-1-yl)propoxy)quinolin-2-yl)methanimine oxide | Definition date: | 2021-11-26 | Last modified: | 2022-11-25 | Release date: | 2022-11-30 | Identifier: | ~{N}-~{tert}-butyl-1-[8-[3-(4-prop-2-ynylpiperazin-1-yl)propoxy]quinolin-2-yl]methanimine oxide |
|
| KGL | Name: | (1^4Z,5^2E)-6^3-(trifluoromethyl)-5^1,5^6-dihydro-1^1H-8-aza-2(3,6)-quinolina-5(1,3)-pyridazina-1(4,1)-pyrazola-6(1,4)-benzenacyclododecaphane-5^6,7-dione | Formula: | C30 H25 F3 N6 O2 | SMILES: | FC(F)(F)c1cc2ccc1C(=O)NCCCCn3cc(cn3)c4cnc5ccc(CC[N]6N=C2C=CC6=O)cc5c4 | InChi: | InChI=1S/C30H25F3N6O2/c31-30(32,33)25-15-20-4-5-24(25)29(41)34-10-1-2-11-38-18-23(17-36-38)22-14-21-13-19(3-6-26(21)35-16-22)9-12-39-28(40)8-7-27(20)37-39/h3-8,13-18H,1-2,9-12H2,(H,34,41) | Definition date: | 2022-09-20 | Last modified: | 2022-11-18 | Release date: | 2022-11-23 |
|
| ZRT | Name: | N-[5-{[(4P)-4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl]amino}-4-methoxy-2-(morpholin-4-yl)phenyl]propanamide | Formula: | C30 H36 N8 O3 | SMILES: | CN(C)Cc1cn(nc1c1ccccc1)c1nc(ncc1)Nc1cc(NC(=O)CC)c(cc1OC)N1CCOCC1 | InChi: | InChI=1S/C30H36N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h6-12,17-18,20H,5,13-16,19H2,1-4H3,(H,32,39)(H,31,33,34) | Synonyms: | lazertinib, bound form | Definition date: | 2022-04-18 | Last modified: | 2022-11-18 | Release date: | 2022-11-23 | Identifier: | N-[5-{[(4P)-4-{4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl}pyrimidin-2-yl]amino}-4-methoxy-2-(morpholin-4-yl)phenyl]propanamide |
|
| M19 | Name: | 4-(5-chloro-4-fluoro-2-hydroxyanilino)-7-methoxyquinazolin-6-ol | Formula: | C15 H11 Cl F N3 O3 | SMILES: | Clc1cc(Nc2ncnc3cc(OC)c(O)cc32)c(O)cc1F | InChi: | InChI=1S/C15H11ClFN3O3/c1-23-14-5-10-7(2-13(14)22)15(19-6-18-10)20-11-3-8(16)9(17)4-12(11)21/h2-6,21-22H,1H3,(H,18,19,20) | Definition date: | 2022-03-11 | Last modified: | 2022-11-18 | Release date: | 2022-11-23 | Identifier: | 4-(5-chloro-4-fluoro-2-hydroxyanilino)-7-methoxyquinazolin-6-ol |
|
| QIA | Name: | 5-[(phenylmethyl)amino]pyrimido[4,5-c]quinoline-8-carboxylic acid | Formula: | C19 H14 N4 O2 | SMILES: | OC(=O)c1ccc2c(c1)nc(NCc3ccccc3)c4ncncc24 | InChi: | InChI=1S/C19H14N4O2/c24-19(25)13-6-7-14-15-10-20-11-22-17(15)18(23-16(14)8-13)21-9-12-4-2-1-3-5-12/h1-8,10-11H,9H2,(H,21,23)(H,24,25) | Definition date: | 2022-10-31 | Last modified: | 2022-11-18 | Release date: | 2022-11-23 | Identifier: | 5-[(phenylmethyl)amino]pyrimido[4,5-c]quinoline-8-carboxylic acid |
|